Latest News and Press Releases

ThromboGenics Announces FDA Acceptance of Investigational New Drug (IND) Application for Phase II Study with JETREA® for the Treatment of Non-Proliferative Diabetic Retinopathy (CIRCLE) ...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Please find attached financial statement for Q3,...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Gross written premiums increase in...

Gebuchte Bruttoprämien steigen in ersten neun Monaten 2015 um 12,1 Prozent auf 24,4 (21,7) Mrd. EUR Operatives Ergebnis (EBIT) wächst um 4,4 Prozent auf 1,5 (1,4) Mrd. EUR Konzernergebnis bei 488...

Third quarter highlights Key indicators: Volume increased 6.4% to 1,670.3 million liters compared to the same period last year (Q3 2014: 1,569.3 million liters). Due to weather related mix...

Aava Mobile and Ingenico Group (Euronext: FR0000125346 - ING), global leader in seamless payment, today announced the launch of a retailer-specific tablet that will combine contactless payment and...

JULI – SEPTEMBER 2015 · Samarbetet med NTU ger tidiga resultat i form av en gemensam patentansökan kring att öka energieffektiviteten för UV-ljuskällor genom s.k. ljusextraktionsteknik. ·...

DGAP-News: Wacker Neuson SE / Key word(s): 9-month figures/Forecast Wacker Neuson SE: Wacker Neuson Group maintains course despite difficult market conditions 12.11.2015 /...

DGAP-News: STADA Arzneimittel AG / Key word(s): Miscellaneous STADA Arzneimittel AG: Nine-month results show strong development in the third quarter - outlook for 2015 confirmed 12.11.2015 /...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Capelle aan den IJssel, the Netherlands - 12...